COMMUNIQUÉS West-GlobeNewswire
-
NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., to Launch Dog Gone Odor® on Chewy and Amazon, Expanding its Rapidly Growing Biosafety Catalog
14/01/2026 -
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
14/01/2026 -
Altanine Shares Industry Perspective on the Future of Generics and the Role of Value-Added Formulations
14/01/2026 -
ApolloMD Announces Leadership Appointments to Strengthen Hospital Operations and Revenue Performance
14/01/2026 -
Patterson Dental and Dentsply Sirona Renew U.S. Dental Technology Distribution Partnership
14/01/2026 -
Statement from Unity Consortium on Announced Changes to the U.S. Childhood and Adolescent Immunization Schedule
14/01/2026 -
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
14/01/2026 -
Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand
14/01/2026 -
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval
14/01/2026 -
C4 Therapeutics Outlines Strategic Milestones to Advance Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader and Discovery Strategy Focused on Novel Targets in Clinically Validated Pathways
14/01/2026 -
Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results
14/01/2026 -
Orion updates time estimate for the potential related to the annual Nubeqa® net sales recorded by Orion
14/01/2026 -
Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045
14/01/2026 -
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
14/01/2026 -
Published Peer-Reviewed Study Demonstrates Nexalin’s DIFS™ Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD
14/01/2026 -
Aeroflow Health and Blue Cross Complete of Michigan Partner to Deliver Essential DME to Medicaid Members
14/01/2026 -
Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics
14/01/2026 -
Counslr Expands Long Island Footprint to Support Mental Health in the New Year
14/01/2026 -
Cannara Achieves OTCQX Qualification and Announces Release of Fiscal Q1 2026 Financial Results on January 26, 2026
14/01/2026
Pages